PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 19, 2026Medical Sciences0 citationsOpen Access

Financial Implications of GI Bleeding in Patients with LVAD: An Analysis from the US National Inpatient Sample Trends

View Full Paper
SBSudhakar BasettyAPAnil PhilipRPROOP SUNIL REDDY PARLAPALLI

Key Points

  • This analysis aims to evaluate the trends and outcomes related to gastrointestinal bleeding in LVAD patients using national data.
  • Analyzed adult LVAD hospitalizations from the National Inpatient Sample (2016–2021).
  • Identified gastrointestinal bleeding via ICD-10 codes and classified it into upper and lower sources.
  • Used regression models to assess associations with mortality, length of stay, and healthcare charges.
  • Conducted subgroup analyses to explore sex and racial disparities.
  • 9.8% of LVAD admissions had gastrointestinal bleeding, primarily lower GI bleeds at 72.3%.
  • Patients with GIB had an average longer hospitalization by 15.3 days and higher charges by $316,031.
  • Increased mortality was associated with GIB, especially among female patients and Black patients with notable length-of-stay differences.

Abstract

Background: Gastrointestinal bleeding (GIB) is a common and serious complication in patients with left ventricular assist devices (LVADs), contributing to significant morbidity, prolonged hospitalization, and increased healthcare costs. We evaluated national trends, demographic disparities, and outcomes of GIB in hospitalized LVAD patients. Methods: We analyzed adult (≥18 years) LVAD hospitalizations in the National Inpatient Sample (2016–2021), identifying internal LVADs using ICD-10-PCS code 02HA0QZ. GIB was defined using ICD-10-CM codes and classified into upper (UGIB) and lower (LGIB) sources. Survey-weighted logistic and linear regression models assessed associations with mortality, length of stay (LOS), and total charges. Subgroup analyses explored sex and racial disparities. Results: Among 20, 785 weighted adult LVAD admissions, 9. 8% had GIB. Of these, 72. 3% had LGIB and 31. 0% had UGIB. Patients with GIB were older (59. 2 vs. 54. 8 years) and more likely to be female (43% vs. 40%) and Black (9. 2% vs. 7. 8%). GIB was associated with longer LOS (+15. 3 days, 95% CI: 12. 0–18. 5), higher charges (+316, 031, 95% CI: 212, 435–419, 627), and greater in-hospital mortality (OR 1. 69, 95% CI: 1. 25–2. 29; p < 0. 001). Female patients with GIB had higher odds of mortality (OR 1. 37) and increased LOS (+5. 6 days), though this was not statistically significant. Racial disparities were evident: Black patients with GIB had longer LOS (+8. 9 days), while Asian/Pacific Islander patients had shorter LOS (–23. 3 days, p < 0. 001). From 2016 to 2021, GIB prevalence rose modestly (from 9. 4% to 10. 7%, p = 0. 33), with no significant change in mortality trends (p = 0. 13). Conclusions: GIB complicates nearly 1 in 10 LVAD hospitalizations, with lower GI bleeds being most common. GIB is independently associated with higher mortality, LOS, and costs. Persistent gender and racial disparities highlight the need for targeted strategies to improve outcomes in this high-risk population.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Basetty et al. (2026) studied this question.

synapsesocial.com/papers/6996a818ecb39a600b3ee8e4https://doi.org/10.3390/medsci14010096
Ask AI
Helpful
Bookmark
Share
View Full Paper